CONMED EBITDA 2010-2025 | CNMD

CONMED ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
CONMED Annual EBITDA
(Millions of US $)
2024 $278
2023 $199
2022 $144
2021 $194
2020 $132
2019 $163
2018 $133
2017 $105
2016 $93
2015 $95
2014 $99
2013 $104
2012 $112
2011 $111
2010 $99
2009 $70
CONMED Quarterly EBITDA
(Millions of US $)
2025-03-31 $36
2024-12-31 $72
2024-09-30 $85
2024-06-30 $66
2024-03-31 $54
2023-12-31 $70
2023-09-30 $50
2023-06-30 $47
2023-03-31 $32
2022-12-31 $18
2022-09-30 $43
2022-06-30 $43
2022-03-31 $40
2021-12-31 $58
2021-09-30 $47
2021-06-30 $47
2021-03-31 $42
2020-12-31 $46
2020-09-30 $51
2020-06-30 $0
2020-03-31 $35
2019-12-31 $50
2019-09-30 $43
2019-06-30 $40
2019-03-31 $30
2018-12-31 $41
2018-09-30 $27
2018-06-30 $32
2018-03-31 $33
2017-12-31 $39
2017-09-30 $28
2017-06-30 $27
2017-03-31 $11
2016-12-31 $27
2016-09-30 $28
2016-06-30 $22
2016-03-31 $17
2015-12-31 $25
2015-09-30 $26
2015-06-30 $23
2015-03-31 $21
2014-12-31 $29
2014-09-30 $14
2014-06-30 $27
2014-03-31 $28
2013-12-31 $29
2013-09-30 $21
2013-06-30 $28
2013-03-31 $28
2012-12-31 $29
2012-09-30 $26
2012-06-30 $28
2012-03-31 $29
2011-12-31 $30
2011-09-30 $27
2011-06-30 $27
2011-03-31 $28
2010-12-31 $24
2010-09-30 $26
2010-06-30 $25
2010-03-31 $24
2009-12-31 $22
2009-09-30 $16
2009-06-30 $15
2009-03-31 $17
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.761B $1.307B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.440B 21.60
Becton Dickinson (BDX) United States $48.912B 12.11
Cardinal Health (CAH) United States $37.110B 19.43
Labcorp (LH) United States $20.968B 17.01
Straumann Holding AG (SAUHY) Switzerland $20.602B 0.00
West Pharmaceutical Services (WST) United States $15.134B 31.72
Cooper (COO) United States $13.381B 17.25
Align Technology (ALGN) United States $12.986B 25.78
Henry Schein (HSIC) United States $8.590B 14.73
Merit Medical Systems (MMSI) United States $5.591B 27.03
DENTSPLY SIRONA (XRAY) United States $3.167B 9.46
STAAR Surgical (STAA) United States $0.849B 0.00
Lifevantage (LFVN) United States $0.162B 16.69
Pro-Dex (PDEX) United States $0.140B 15.28